Does LEVETIRACETAM Cause Basal cell carcinoma? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Basal cell carcinoma have been filed in association with LEVETIRACETAM (Levetiracetam). This represents 0.0% of all adverse event reports for LEVETIRACETAM.
24
Reports of Basal cell carcinoma with LEVETIRACETAM
0.0%
of all LEVETIRACETAM reports
0
Deaths
13
Hospitalizations
How Dangerous Is Basal cell carcinoma From LEVETIRACETAM?
Of the 24 reports, 13 (54.2%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVETIRACETAM. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does LEVETIRACETAM Cause?
Seizure (9,961)
Drug ineffective (8,666)
Off label use (5,789)
Maternal exposure during pregnancy (3,197)
Foetal exposure during pregnancy (2,604)
Epilepsy (2,546)
Generalised tonic-clonic seizure (2,276)
Somnolence (2,070)
Fatigue (1,972)
Status epilepticus (1,883)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which LEVETIRACETAM Alternatives Have Lower Basal cell carcinoma Risk?
LEVETIRACETAM vs LEVOBUNOLOL
LEVETIRACETAM vs LEVOBUPIVACAINE
LEVETIRACETAM vs LEVOCARNITINE
LEVETIRACETAM vs LEVOCETIRIZINE
LEVETIRACETAM vs LEVODOPA